AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers

AKR1D1*36 C>T (rs1872930) allelic variant is associated with variability of the CYP2C9 genotype predicted pharmacokinetics of ibuprofen enantiomers – a pilot study in healthy volunteers

The relative contribution of CYP2C9 allelic variants to the pharmacokinetics (PK) of ibuprofen (IBP) enantiomers has been studied extensively, but the potential clinical benefit of pharmacogenetically guided IBP treatment is not evident yet. The role of AKR1D1*36C>T (rs 1872930) allelic variant i...

Full description

Saved in:
Bibliographic Details
Main Authors: Kapedanovska Nestorovska Aleksandra, Jakjovski Krume, Naumovska Zorica, Sterjev Zoran, Geskovska Nadica Matevska, Mladenovska Kristina, Suturkova Ljubica, Dimovski Aleksandar
Format: Article
Language:English
Published: Sciendo 2019-09-01
Series:Acta Pharmaceutica
Subjects:
ibuprofen
enantiomers
pharmacokinetics
akr1d1
cyp2c9
pharmacogenetics
Online Access:https://doi.org/10.2478/acph-2019-0032
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.2478/acph-2019-0032

Similar Items